drugset / Trial / NCT00471094
Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the efficacy and safety of 8 weeks of daily treatment with Ilaprazole (5, 20 and 40 mg), once daily (QD), compared to lansoprazole 30 mg in healing subjects with endoscopically proven erosive esophagitis.
Timeline
- Start
- 2007-05
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ilaprazole | Small molecule | 5 mg | Oral |
| Subject | Ilaprazole | Small molecule | 20 mg | Oral |
| Subject | Ilaprazole | Small molecule | 40 mg | Oral |
| Comparator | Lansoprazole | Other / unclassified | 30 mg | Oral |